Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label darunavir/ritonavir pharmacokinetic and antiviral study in treatment-experienced HIV-1 infected children aged 3 to under 6 years
2008-004630-25Phase 2
- Sponsor
- Tibotec
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of darunavir and ritonavir in Human immunodeficiency virus infection type 1, sponsored by Tibotec. Primary endpoint: Primary analysis.
02
Drugs
darunavirritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-004630-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004630-25.